skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier

Journal Article · · Journal of Biological Chemistry
 [1];  [2];  [3]; ORCiD logo [4]
  1. La Jolla Inst. for Allergy and Immunology (LJI), La Jolla, CA (United States). Division of Immune Regulation
  2. SLAC National Accelerator Lab., Menlo Park, CA (United States). Stanford Synchrotron Radiation Lightsource (SSRL)
  3. La Jolla Inst. for Allergy and Immunology (LJI), La Jolla, CA (United States). Division of Immune Regulation; Univ. of California, San Diego, CA (United States). Dept. of Medicine
  4. La Jolla Inst. for Allergy and Immunology (LJI), La Jolla, CA (United States). Division of Immune Regulation; Ghent Univ., Ghent (Belgium). Dept. of Internal Medicine, Faculty of Medicine and Health Sciences

Human (h)4-1BB (TNFRSF9 or CD137) is an inducible tumor necrosis factor receptor (TNFR) superfamily member that interacts with its cognate ligand h4-1BBL to promote T lymphocyte activation and proliferation. h4-1BB is currently being targeted with agonists in cancer immunotherapy. Here, we determined the crystal structures of unbound h4-1BBL and both WT h4-1BB and a dimerization-deficient h4-1BB mutant (C121S) in complex with h4-1BBL at resolutions between 2.7 and 3.2 Å. Here, we observed that the structural arrangement of 4-1BBL, both unbound and in the complex, represents the canonical bell shape as seen in other similar TNF proteins and differs from the previously reported three-bladed propeller structure of 4-1BBL. We also found that the binding site for the receptor is at the crevice formed between two protomers of h4-1BBL, but that h4-1BB interacts predominantly with only one ligand protomer. Moreover, h4-1BBL lacked the conserved tyrosine residue in the DE loop that forms canonical interactions between other TNFR family molecules and their ligands, suggesting h4-1BBL engages h4-1BB through a distinct mechanism. Of note, we discovered that h4-1BB forms a disulfide-linked dimer because of the presence of an additional cysteine residue found in its cysteine-rich domain 4 (CRD4). As a result, h4-1BB dimerization, in addition to trimerization via h4-1BBL binding, could result in cross-linking of individual ligand–receptor complexes to form a 2D network that stimulates strong h4-1BB signaling. Finally, this work provides critical insights into the structural and functional properties of both h4-1BB and h4-1BBL and reveals that covalent receptor dimerization amplifies h4-1BB signaling.

Research Organization:
SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States)
Sponsoring Organization:
USDOE; National Institutes of Health (NIH)
Grant/Contract Number:
AC02-76SF00515; AI110929
OSTI ID:
1463891
Journal Information:
Journal of Biological Chemistry, Vol. 293, Issue 26; ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular BiologyCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 20 works
Citation information provided by
Web of Science

References (39)

Phase I study of BMS-663513, a fully human anti-CD137 agonist monoclonal antibody, in patients (pts) with advanced cancer (CA) journal May 2008
The role of TNF superfamily members in T-cell function and diseases journal April 2009
Structural and Functional Insights of RANKL–RANK Interaction and Signaling journal May 2010
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors journal June 1997
Overview of the CCP 4 suite and current developments journal March 2011
The Crystal Structure of the Costimulatory OX40-OX40L Complex journal August 2006
Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation journal May 1993
Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies journal June 2014
Crystal Structure of TRAIL-DR5 Complex Identifies a Critical Role of the Unique Frame Insertion in Conferring Recognition Specificity journal July 2000
CD137-CRDI is not necessary in the role of contacting its natural ligand journal August 2016
The TNF and TNF Receptor Superfamilies journal February 2001
Solution of the Structure of the TNF-TNFR2 Complex journal November 2010
Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation journal February 2011
Immune regulation and control of regulatory T cells by OX40 and 4-1BB journal June 2008
Evolution of GITRL immune function: Murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily journal January 2008
The molecular architecture of the TNF superfamily journal January 2002
The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily journal December 2009
Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand journal July 2009
Identification and Characterization of Galectin-9, a Novel β-Galactoside-binding Mammalian Lectin journal February 1997
Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling journal December 2017
Dual immunoregulatory pathways of 4-1BB signaling journal August 2006
Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. journal May 1997
RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor journal November 2012
Three is better than one: Pre-ligand receptor assembly in the regulation of TNF receptor signaling journal February 2007
T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy: Effects of GITR and 4-1BB on T cells journal October 2011
4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells journal February 1994
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity journal March 2012
Crystal Structure of Human RANKL Complexed with Its Decoy Receptor Osteoprotegerin journal June 2012
Decoy Strategies: The Structure of TL1A:DcR3 Complex journal February 2011
Sequence, structure, function, immunity: structural genomics of costimulation journal May 2009
Integration, scaling, space-group assignment and post-refinement journal January 2010
The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody journal April 1983
Role of 4-1BB in immune responses journal December 1998
Likelihood-enhanced fast translation functions journal March 2005
Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function journal November 2007
Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy journal February 2016
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome journal December 2019
Solution of the structure of the TNF-TNFR2 complex journal August 2011
Overview of the CCP4 suite and current developments. text January 2011

Cited By (3)

Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding journal December 2018
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy journal June 2019
377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects conference November 2020